Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 202-207

  Jodele, Sonata ^a   Hirsch, Russel ^a   Laskin, Benjamin ^a   Davies, Stella ^a   Witte, David ^a   Chima, Ranjit ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Hematopoietic stem cell transplant; Pediatrics; Pulmonary arterial hypertension; Respiratory failure; Transplantation associated thrombotic microangiopathy

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN; NITRIC OXIDE; RITUXIMAB; SILDENAFIL; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOPSY; CHILD; CHILDHOOD DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FANCONI ANEMIA; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN TISSUE; HYPOXEMIA; LYMPHOPROLIFERATIVE DISEASE; MALE; MEDICAL RECORD REVIEW; PROTEINURIA; PULMONARY HYPERTENSION; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSPLANTATION ASSOCIATED THROMBOTIC MICROANGIOPATHY;

CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; THROMBOTIC MICROANGIOPATHIES;

EID: 84872618131     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.08.022     Document Type: Article

References (30)

1. Schannwell C.M., Steiner S., Strauer B.E. Diagnostics in pulmonary hypertension. J Physiol Pharmacol 2007, 58(Suppl 5(Pt 2)):591-602.
2. Berger R.M., Beghetti M., Humpl T., et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet 2012, 379:537-546.
3. Houtchens J., Martin D., Klinger J.R. Diagnosis and management of pulmonary arterial hypertension. Pulm Med 2011, 2011:845864.
4. Friedman D., Szmuszkovicz J., Rabai M., Detterich J.A., Menteer J., Wood J.C. Systemic endothelial dysfunction in children with idiopathic pulmonary arterial hypertension correlates with disease severity. J Heart Lung Transplant 2012, 31:642-647.
5. Diller G.P., Thum T., Wilkins M.R., Wharton J. Endothelial progenitor cells in pulmonary arterial hypertension. Trends Cardiovasc Med 2010, 20:22-29.
6. Price L.C., Wort S.J., Perros F., et al. Inflammation in pulmonary arterial hypertension. Chest 2012, 141:210-221.
7. Barnes T., Gliddon A., Doré C.J., Maddison P., Moots R.J. Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis. Rheumatology (Oxford) 2012, 51:1606-1609. for the QUINs Trial Study Group.
8. Schermuly R.T., Ghofrani H.A., Wilkins M.R., Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 2011, 8:443-455.
9. Gupta S.K., Saxena A., Gulati G.S. Evaluation of pulmonary hypertension in a child: role of computed tomography. Indian J Pediatr 2011, 78:1417-1419.
10. Barbosa E.J., Gupta N.K., Torigian D.A., Gefter W.B. Current role of imaging in the diagnosis and management of pulmonary hypertension. AJR Am J Roentgenol 2012, 198:1320-1331.
11. Sato T., Tsujino I., Ohira H., et al. Validation study on the accuracy of echocardiographic measurements of right ventricular systolic function in pulmonary hypertension. J Am Soc Echocardiogr 2012, 25:280-286.
12. Freed B.H., Patel A.R., Lang R.M. Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension. Curr Cardiol Rep 2012, 14:366-373.
13. Wahl S., Vichinsky E. Pulmonary hypertension in hemolytic anemias. F1000 Med Rep 2010, 2:10.
14. Farmakis D., Aessopos A. Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked. Circulation 2011, 123:1227-1232.
15. Parent F., Bachir D., Inamo J., et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 2011, 365:44-53.
16. Perkowska-Ptasinska A., Sulikowska-Rowinska A., Pazik J., Komuda-Leszek E., Durlik M. Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report. Transplant Proc 2006, 38:295-296.
17. Kuga T., Kohda K., Hirayama Y., et al. Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia. Int J Hematol 1996, 64:143-150.
18. Laskin B.L., Goebel J., Davies S.M., Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011, 118:1452-1462.
19. Ho V.T., Cutler C., Carter S., et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11:571-575.
20. Seguchi M., Hirabayashi N., Fujii Y., et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000, 69:177-179.
21. Shankar S., Choi J.K., Dermody T.S., Head D.R., Bunin N., Iannone R. Pulmonary hypertension complicating bone marrow transplantation for idiopathic myelofibrosis. J Pediatr Hematol Oncol 2004, 26:393-397.
22. Vaksmann G., Nelken B., Deshildre A., Rey C. Pulmonary arterial occlusive disease following chemotherapy and bone marrow transplantation for leukaemia. Eur J Pediatr 2002, 161:247-249.
23. Cho B.S., Yahng S.A., Lee S.E., et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 2010, 90:918-926.
24. Cooke K.R., Jannin A., Ho V. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008, 14(1 Suppl 1):23-32.
25. Goldberg R.J., Nakagawa T., Johnson R.J., Thurman J.M. The role of endothelial cell injury in thrombotic microangiopathy. Am J Kidney Dis 2010, 56:1168-1174.
26. Chopra S., Badyal D.K., Baby P.C., Cherian D. Pulmonary arterial hypertension: advances in pathophysiology and management. Indian J Pharmacol 2012, 44:4-11.
27. Ghofrani H.A., Distler O., Gerhardt F., et al. Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011, 154(Suppl 1):S20-S33.
28. Galiè N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537. Erratum in: Eur Heart J. 2011;32:926.
29. Saxena A. Pulmonary hypertension-" state of the art" management in 2012. Indian Heart J 2012, 64:60-73.
30. Ivy D. Advances in pediatric pulmonary arterial hypertension. Curr Opin Cardiol 2012, 27:70-81.